Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

BACKGROUND: Patients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation. We hypothesized that patients with liver cirrhosis would have a positive net clinical benefit for oral anticoagulation when used...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ling, Chao, Tze‐Fan, Liu, Chia‐Jen, Lin, Yenn‐Jiang, Chang, Shih‐Lin, Lo, Li‐Wei, Hu, Yu‐Feng, Tuan, Ta‐Chuan, Liao, Jo‐Nan, Chung, Fa‐Po, Chen, Tzeng‐Ji, Lip, Gregory Y. H., Chen, Shih‐Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669162/
https://www.ncbi.nlm.nih.gov/pubmed/28645935
http://dx.doi.org/10.1161/JAHA.116.005307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669162/
https://www.ncbi.nlm.nih.gov/pubmed/28645935
http://dx.doi.org/10.1161/JAHA.116.005307

Ejemplares similares